Neuronetics holder plans sale of 121K shares

Neuronetics, Inc. (STIM) has a notice under Rule 144 for a proposed sale of its common stock held for the account of William A. Macan.

Rhea-AI Filing Summary

Neuronetics, Inc. (STIM) has a notice under Rule 144 for a proposed sale of its common stock held for the account of William A. Macan. The filing indicates up to 121,033 shares of common stock are covered, to be sold through Fidelity Brokerage Services LLC on NASDAQ. The shares relate to restricted stock vesting dated August 14, 2026, and the sale includes an amount necessary to cover a tax obligation arising from the settlement of a vested equity award distribution.

Key Figures

Shares Covered by Form 144: 121033 shares Aggregate Market Value: 388273.87 Vesting Date: 08/14/2026 +1 more

4 metrics

Shares Covered by Form 144 121033 shares Common stock of Neuronetics, Inc. covered by the Rule 144 notice

Aggregate Market Value 388273.87 Value associated with the 121,033 Neuronetics common shares listed in the notice

Vesting Date 08/14/2026 Date of restricted stock vesting that generated the shares to be sold

Date of Notice 08/18/2026 Date on which the Rule 144 notice for Neuronetics common stock was filed

Key Terms

Rule 144, restricted stock vesting, vested equity award distribution, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 08/14/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award distribution financial

"resulting from the settlement of a vested equity award distribution."

attorney-in-fact regulatory

"as attorney-in-fact for William A. Macan"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Neuronetics, Inc. (STIM) disclose?

The Form 144 filing discloses a proposed sale of up to 121,033 shares of Neuronetics, Inc. common stock for the account of William A. Macan. The shares are to be sold under Rule 144 through Fidelity Brokerage Services LLC on NASDAQ.

How many Neuronetics (STIM) shares are covered by this Rule 144 notice?

The notice covers up to 121,033 shares of Neuronetics, Inc. common stock. This represents the amount tied to a restricted stock vesting event and includes shares expected to be sold to address related tax obligations.

Who is the selling security holder in the Neuronetics (STIM) Form 144?

The securities are held for the account of William A. Macan. Fidelity Brokerage Services LLC is identified as the broker, and the notice is signed by a duly authorized representative acting as attorney-in-fact for William A. Macan.

What is the origin of the Neuronetics (STIM) shares to be sold under this Form 144?

The shares originate from restricted stock vesting on August 14, 2026. The filing states the sale includes an amount needed to cover a tax obligation from the settlement of a vested equity award distribution.

On which market are the Neuronetics (STIM) shares in the Form 144 expected to trade?

The Form 144 identifies NASDAQ as the market for the proposed sale of Neuronetics, Inc. common stock. Fidelity Brokerage Services LLC is listed as the brokerage firm handling the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:47 PM Accepted by SEC EDGAR 08/18/2026 - 04:46 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001758584
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Neuronetics, Inc.
SEC File Number	001-38546
Address of Issuer	3222 PHOENIXVILLE PIKE MALVERN PENNSYLVANIA 19355
Phone	877-600-7555
Name of Person for Whose Account the Securities are To Be Sold	MACAN WILLIAM ANDREW
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	121033	388273.87	76197222	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/14/2026	Restricted Stock Vesting	Issuer			121033	08/14/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for William A. Macan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)